(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

XENOTHERA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

XENOTHERA

ST13

US500000079418084

Class

5

Filing

79418084

Registration

8131734

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

08/14/2026

Trademark type

Word

Nice classes

5

Filing date

01/20/2025

Registration date

02/10/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/10/2026

Last transaction

08/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

34

Owner location

FR

Examiner

MORRIS, KRISTINA KLOIBER

Law office

M70

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

XENOTHERA

Representatives

Ronald M. Kachmarik Cooper Legal Group LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products and preparations for the diagnosisprevention and treatment of oncologicalhaematologicalimmunological and infectious diseasesfor xenotransplantation; polyclonal antibodies for medicalpharmaceutical and veterinary use; monoclonal antibodies for medicalpharmaceutical and veterinary use; diagnostic preparations and diagnostic biomarker reagents for medical use; chemical and biological preparations for medical or pharmaceutical usefor the diagnosisprevention and treatment of oncologicalhaematologicalimmunological and infectious diseasesfor xenotransplantation; chemical reagents for medical or veterinary use

Publications

History of USPTO decisions and trademark events.

29 publications found

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/14/2026

FIMP

FINAL DISPOSITION PROCESSED

08/13/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

08/13/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/27/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

07/26/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/10/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/10/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/10/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/23/2025

PUBO

PUBLISHED FOR OPPOSITION

12/23/2025

GPNX

NOTIFICATION PROCESSED BY IB

12/18/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/17/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/03/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

12/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/21/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/19/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/19/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/19/2025

RFNT

REFUSAL PROCESSED BY IB

09/05/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/16/2025

RFRR

REFUSAL PROCESSED BY MPU

08/16/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/09/2025

CNRT

NON-FINAL ACTION WRITTEN

07/08/2025

DOCK

ASSIGNED TO EXAMINER

06/30/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/19/2025

MAFR

APPLICATION FILING RECEIPT MAILED

03/21/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/21/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

03/21/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/27/2025

Continuous trademark protection

Get notified about every new filing that threatens XENOTHERA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.